Aquila BioMedical signed an extended contract with Macrophage Pharma to support its preclinical immuno-oncology programs.
Part of an international initiative, a pan-European observational study aims to improve clinical care of traumatic brain injury.
The complex and intertwined dual epidemics of poorly treated pain and opioid addiction require a combined, artful approach to secure the best possible results…
About a year after QuintilesIMS was born from a megamerger between Quintiles and IMS Health, the contract research giant has decided to turn the page.
Bioclinica is looking to broaden its reach with the purchase of MDDX Research & Informatics.
Concept Life Sciences bought Acquila Biomedical for its translational biology capabilities.
Imricor Medical Systems and Mirtle Medical are combining their offerings to create an alternative to x-ray guided ablation.
Major CRO player PPD has won a lucrative seven-year government contract in infectious disease.
Clinerion inks a new deal that adds 60 million U.S. patients to its clinical trial patient recruitment system.
Medical devices-focused CRO Factory has expanded in North America with the acquisition of Milestone.
Charles River builds in vitro 3D tumor microtissues derived from its PDXs using InSphero's 3D cell culture solutions.